Donghua Wen
- Endocrinology top 5%
- Infectious Diseases top 10%
- SARS-CoV-2 detection and testing 3
- SARS-CoV-2 and COVID-19 Research 2
-
- Antibiotic Resistance in Bacteria 2
-
- Ubiquitin and proteasome pathways 4
- Retinoids in leukemia and cellular processes 2
-
- Pneumonia and Respiratory Infections 2
-
- Microtubule and mitosis dynamics 2
-
- Bacterial Identification and Susceptibility Testing 2
- Co-authors
- Wenjuan WuZheng FuXueen FangJing WuQiuyuan LinJilie KongYingli WuGuoqiang Chen
- Journals
- PLoS ONE (1 paper)Analytical Chemistry (1 paper)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Donghua Wen
18 papers receiving 597 citations
Peers
Comparison fields: 5 of 92
- Endocrinology 70
- Infectious Diseases 162
- Molecular Medicine 33
- Molecular Biology 367
- Oncology 95
Countries citing papers authored by Donghua Wen
This map shows the geographic impact of Donghua Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghua Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghua Wen more than expected).
Fields of papers citing papers by Donghua Wen
This network shows the impact of papers produced by Donghua Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghua Wen. The network helps show where Donghua Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donghua Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 8 | |
| 6 | 2021 | 30 | |
| 7 | 2020 | 163 | |
| 8 | 2020 | 1 | |
| 9 | 2018 | 25 | |
| 10 | 2017 | 93 | |
| 11 | 2017 | 49 | |
| 12 | 2017 | 45 | |
| 13 | 2014 | 16 | |
| 14 | 2014 | 59 | |
| 15 | 2012 | 39 | |
| 16 | 2011 | 43 | |
| 17 | 2011 | 10 | |
| 18 | 2009 | 13 |
About Donghua Wen
Donghua Wen is a scholar working on Molecular Medicine, Clinical Biochemistry and Endocrinology, having authored 18 papers that have together received 607 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), SARS-CoV-2 detection and testing (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Pneumonia and Respiratory Infections (2 papers), Antibiotic Resistance in Bacteria (2 papers), Microtubule and mitosis dynamics (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Endocrinology (70 citations), Infectious Diseases (162 citations) and Molecular Medicine (33 citations). Donghua Wen has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Wenjuan Wu, Zheng Fu, Xueen Fang, Jing Wu, Qiuyuan Lin, Jilie Kong, Yingli Wu, Guoqiang Chen, Jian Wu and Lei Wang. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.